BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thuret, G
Right arrow Articles by Gain, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thuret, G
Right arrow Articles by Gain, P
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2003;87:346-352
© 2003 BMJ Publishing Group


LABORATORY SCIENCE

Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line

G Thuret1, C Chiquet1, S Herrag1, J-M Dumollard1, D Boudard1, J Bednarz2, L Campos1, P Gain1

1 "Cell death and neoplasia laboratory", EA 3063, University of Saint-Etienne, France
2 Universitäts-Augenklinik Eppendorf, Hamburg, Germany

Correspondence to:
Correspondence to:
Philippe Gain, Department of Ophthalmology, Pavillon 50A, Hôpital Bellevue, CHU Saint-Etienne, 42055 Saint-Etienne Cedex 2, France;
philippe.gain{at}univ-st-etienne.fr

Background: Apoptosis very probably plays a key part in endothelial cell loss during corneal storage in organ culture as well as hypothermic storage. However, the mechanisms underlying endothelial apoptosis are poorly understood. The response of a human corneal endothelial cell (HCEC) line to staurosporine, a known inducer of apoptosis, was investigated to gain insights into the intracellular modulators that participate in endothelial cell death.

Methods: Immortalised HCECs were studied after 3, 6, 12, and 24 hours of incubation with 0.2 µM staurosporine. Cell shedding was monitored. Hoechst 33342 fluorescent DNA staining combined with propidium iodide was used for apoptosis/necrosis quantification and morphological examination. The caspase-3 active form was assessed using western blot, proteolytic activity detection, and immunocytochemistry. The cleaved form of poly(ADP-ribose) polymerase (PARP) was assessed using immunocytochemistry and western blot. The ultrastructural features of cells were screened after 12 hours with staurosporine or vehicle.

Results: The specific apoptotic nature of staurosporine induced HCEC death was confirmed. The ultrastructural features of staurosporine treated cells were typical of apoptosis. HCEC shedding and DNA condensation increased with time. Caspase-3 activity was detected as early as 3 hours after exposure with staurosporine, peaking at 12 hours of incubation. The presence of cleaved PARP after 3 hours confirmed caspase-3 activation.

Conclusions: These data suggest strongly that HCEC cell death induced by staurosporine is apoptosis. The main consequence of HCEC apoptosis is shedding. Staurosporine induced apoptosis of endothelial cells involves activation of caspase-3, and could be a useful model to study strategies of cell death inhibition.



Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2003 87: 253. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
T. Takashina and M. Nakayama
Modifications enhance the apoptosis-inducing activity of FADD
Mol. Cancer Ther., June 1, 2007; 6(6): 1793 - 1803.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.